Smith Shellnut Wilson’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,470
Closed -$146K 168
2021
Q1
$146K Sell
10,470
-233
-2% -$3.8K 0.09% 131
2020
Q4
$201K Buy
+10,703
New +$175K 0.12% 128
2019
Q2
Sell
-8,513
Closed -$241K 136
2019
Q1
$241K Hold
8,513
0.19% 111
2018
Q4
$233K Hold
8,513
0.25% 93
2018
Q3
$312K Buy
+8,513
New +$320K 0.28% 70
2018
Q1
$350K Buy
8,513
+338
+4% +$14.4K 0.3% 52
2017
Q4
$346K Sell
8,175
-8,607
-51% -$329K 0.29% 71
2017
Q3
$526K Sell
16,782
-2,025
-11% -$68.7K 0.46% 45
2017
Q2
$813K Buy
18,807
+2,025
+12% +$77.7K 0.84% 23
2017
Q1
$654K Sell
16,782
-2,025
-11% -$81.6K 0.6% 34
2016
Q4
$717K Buy
+18,807
New +$699K 0.69% 28

Other funds holding VTRS

Smith Shellnut Wilson's VTRS Position: Q2 2021 in Review

Smith Shellnut Wilson sold out of Viatris (VTRS) in Q2 2021, closing a stake of 10,470 shares — an estimated $146K sold.

Smith Shellnut Wilson first reported a position in VTRS in Q4 2016 and held it in 11 quarters. The position peaked at $813K in Q2 2017. 1,044 funds tracked by Wall St. Rank hold VTRS as of Q2 2021.

  • Smith Shellnut Wilson reported no remaining Viatris position as of Q2 2021 after selling out during the quarter.
  • Smith Shellnut Wilson sold 10,470 Viatris shares in Q2 2021, an estimated $146K.
  • Smith Shellnut Wilson first reported a position in Viatris in Q4 2016 and held it in 11 quarters.
  • Smith Shellnut Wilson's Viatris position peaked at $813K in Q2 2017.
  • 1,044 funds tracked by Wall St. Rank held Viatris as of Q2 2021.

Based on Smith Shellnut Wilson's 13F filing for Q2 2021, filed 12 Aug 2021.